Keywords: vaccine, market, potential, immunity, tort, claims, support

US vaccine market potential and immunity from tort claims support Pfizer's Wyeth buy

Article | 02 March 2009

Print This

The agreed $68.0 billion takeover by global drug behemoth Pfizer for its fellow USA-based major Wyeth has brought into focus one ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in